JP2017101118A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017101118A5 JP2017101118A5 JP2015233571A JP2015233571A JP2017101118A5 JP 2017101118 A5 JP2017101118 A5 JP 2017101118A5 JP 2015233571 A JP2015233571 A JP 2015233571A JP 2015233571 A JP2015233571 A JP 2015233571A JP 2017101118 A5 JP2017101118 A5 JP 2017101118A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- salt
- formula
- compound
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 16
- 239000011780 sodium chloride Substances 0.000 claims 16
- 125000004432 carbon atoms Chemical group C* 0.000 claims 10
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 239000003153 chemical reaction reagent Substances 0.000 claims 8
- 125000003277 amino group Chemical group 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 150000001408 amides Chemical class 0.000 claims 5
- 229960003638 dopamine Drugs 0.000 claims 5
- 150000002148 esters Chemical class 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical group 0.000 claims 5
- 125000006239 protecting group Chemical group 0.000 claims 5
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-Hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 claims 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229920002866 paraformaldehyde Polymers 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 238000003260 fluorescence intensity Methods 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- -1 iron ion Chemical class 0.000 claims 1
- 210000002569 neurons Anatomy 0.000 claims 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
Claims (12)
A−S−B (I)
(ここで、式(I)中、Aは、下記の式(A−1)〜(A−13)からなる群より選択されるいずれか一つを示し:
また、式(I)中、Bは、下記式(B)で表される:
また、式(I)中、Sは炭素数2もしくは4のアルケニル基、または、炭素数2もしくは4のアルキニル基を示す。) A compound represented by the following general formula (I) or a salt thereof:
A-S-B (I)
(In the formula (I), A represents any one selected from the group consisting of the following formulas (A-1) to (A-13):
In the formula (I), B is represented by the following formula (B):
In formula (I), S represents an alkenyl group having 2 or 4 carbon atoms or an alkynyl group having 2 or 4 carbon atoms. )
前記式(I)中、Aが、下記の式(A−5)、(A−7)、(A−8)、(A−12)、または、(A−13)である、化合物またはその塩:
In the above formula (I), A is the following formula (A-5), (A-7), (A-8), (A-12), or (A-13), or a compound thereof salt:
前記式(I)中、Aが、下記の式(A−5)または(A−7)である、化合物またはその塩:
In the formula (I), a compound represented by the following formula (A-5) or (A-7) or a salt thereof:
前記式(I)中、Sが炭素数2のアルケニル基である、化合物またはその塩。 A compound according to any one of claims 1-3,
In the above formula (I), a compound or a salt thereof, wherein S is an alkenyl group having 2 carbon atoms.
(a)下記式(III)で示される化合物、パラホルムアルデヒド、および、炭素数2〜4のアルコールを含む溶媒中に4−ヒドロキシベンズアルデヒドを溶解させる工程を含む、製造方法:
(a) A production method comprising a step of dissolving 4-hydroxybenzaldehyde in a solvent containing a compound represented by the following formula (III), paraformaldehyde, and an alcohol having 2 to 4 carbon atoms:
(a)下記式(III)で示される化合物、パラホルムアルデヒド、および、炭素数2〜4のアルコールを含む溶媒中に4−ヒドロキシベンズアルデヒドを溶解させる工程と、
(b)前記工程(a)により得られた化合物および蛍光色素を、炭素数1〜4のアルコールと第二級アミンまたは第三級アミンとを含む溶媒中で反応させる工程と、
(c)前記工程(b)で得られた化合物の保護基を、塩基性条件下で脱保護する工程と、
を含む、製造方法。 A process for producing a compound of formula (I), comprising:
(A) dissolving 4-hydroxybenzaldehyde in a solvent containing a compound represented by the following formula (III), paraformaldehyde, and an alcohol having 2 to 4 carbon atoms;
(B) reacting the compound obtained in the step (a) and the fluorescent dye in a solvent containing an alcohol having 1 to 4 carbon atoms and a secondary amine or a tertiary amine;
(C) deprotecting the protecting group of the compound obtained in the step (b) under basic conditions;
Manufacturing method.
ドーパミンを測定したい部位に請求項6または7に記載の蛍光試薬を投与する工程と、
当該蛍光試薬の蛍光を測定する工程と、
を含む、方法。 A method for detecting or measuring dopamine released from nerve cells in a living body,
Administering the fluorescent reagent according to claim 6 or 7 to a site where dopamine is to be measured;
Measuring the fluorescence of the fluorescent reagent;
Including a method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015233571A JP6685546B2 (en) | 2015-11-30 | 2015-11-30 | Fluorescent substance for dopamine detection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015233571A JP6685546B2 (en) | 2015-11-30 | 2015-11-30 | Fluorescent substance for dopamine detection |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017101118A JP2017101118A (en) | 2017-06-08 |
JP2017101118A5 true JP2017101118A5 (en) | 2018-12-13 |
JP6685546B2 JP6685546B2 (en) | 2020-04-22 |
Family
ID=59016980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015233571A Active JP6685546B2 (en) | 2015-11-30 | 2015-11-30 | Fluorescent substance for dopamine detection |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6685546B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109971478B (en) * | 2017-12-28 | 2023-05-26 | 南京工业大学 | Method for detecting dopamine by using terbium ion doped nano particles in fluorescence dual-wavelength manner |
JP7450254B2 (en) * | 2019-06-28 | 2024-03-15 | 国立研究開発法人産業技術総合研究所 | How to measure neurotransmitters |
CN111829999B (en) * | 2020-07-23 | 2021-06-25 | 重庆大学 | Application method of perovskite fluorescent microsphere and dopamine system |
-
2015
- 2015-11-30 JP JP2015233571A patent/JP6685546B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2014117188A (en) | METHOD FOR PRODUCING 4,4-DIFTOR-3,4-DIHYDROISOCHINOLINE DERIVATIVES | |
RU2018111201A (en) | FUNGICIDAL COMPOSITION FOR APPLICATION IN AGRICULTURE AND GARDENING | |
EP4248988A3 (en) | Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell | |
JP2014510114A5 (en) | ||
JP2017508789A5 (en) | ||
RU2015103694A (en) | METHODS FOR SYNTHESIS OF SPIRO-OXINDOL COMPOUNDS | |
PE20160678A1 (en) | MARKED MEMBRANE-SPECIFIC PROSTATIC ANTIGEN INHIBITORS (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER | |
EA201890752A1 (en) | METHOD OF OBTAINING ANTI-FIBER CONNECTIONS | |
CY1124387T1 (en) | METHOD FOR PRODUCING A NEW NITROGEN-CONTAINING CHEMICAL COMPOUND OR SALT THEREOF, AND PRODUCING AN INTERMEDIATE THEREOF | |
RU2015113638A (en) | CRYSTALLINE SUBSTANCE AND PHARMACEUTICAL PRODUCT CONTAINING IT | |
JP2014520901A5 (en) | ||
RU2019131147A (en) | NEW CHINAZOLINE DERIVATIVES INHIBITING PI3K AND THEIR PHARMACEUTICAL COMPOSITION | |
JP2017515919A5 (en) | ||
CY1121484T1 (en) | SALT AND CRYSTAL FORMS OF AN SUSPENDER PLK-4 | |
JP2017101118A5 (en) | ||
JP2014043437A5 (en) | Organic compounds | |
RU2014129937A (en) | METHODS AND INTERMEDIATE COMPOUNDS FOR PRODUCING PHARMACEUTICAL AGENTS | |
JP2014167003A5 (en) | ||
RU2014124531A (en) | (1R, 4R) 7-OXO-2-AZABICYCLO [2.2.2] OCT-5-EH AND ITS DERIVATIVES | |
RU2018104555A (en) | NEW CONNECTION SPECIFICALLY RELATING TO THE AMPA RECEPTOR | |
JP2015524456A5 (en) | ||
RU2015120527A (en) | Ethyl ethers of 2-amino-1-benzoylamino-4-oxo-5- (2-oxo-2-arylethylidene) -4,5-dihydro-1H-pyrrolidine-3-carboxylic acids, which is beneficial in some respects. | |
JP2016507477A5 (en) | ||
CU20120041A7 (en) | NEW DIHIDRO-OXAZOLOBENZODIAZEPINONAS DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
EA201400437A1 (en) | Method of producing alcoxyaryl ether |